These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12669376)

  • 1. Targeting hepatitis C virus translation: stopping HCV where it starts.
    Jubin R
    Curr Opin Investig Drugs; 2003 Feb; 4(2):162-7. PubMed ID: 12669376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3.
    Yasmeen A; Hamid S; Granath FN; Lindström H; Elliott RM; Siddiqui AA; Persson MA
    J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
    Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
    Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
    Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
    Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
    Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
    J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein.
    Shimazaki T; Honda M; Kaneko S; Kobayashi K
    Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation.
    Wang H; Shen XT; Ye R; Lan SY; Xiang L; Yuan ZH
    Arch Virol; 2005 Jun; 150(6):1085-99. PubMed ID: 15747050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
    Pudi R; Ramamurthy SS; Das S
    J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hnRNP L is required for the translation mediated by HCV IRES.
    Hwang B; Lim JH; Hahm B; Jang SK; Lee SW
    Biochem Biophys Res Commun; 2009 Jan; 378(3):584-8. PubMed ID: 19061868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C IRES: translating translation into a therapeutic target.
    Jubin R
    Curr Opin Mol Ther; 2001 Jun; 3(3):278-87. PubMed ID: 11497352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy.
    Ogata K; Kashiwagi T; Iwahashi J; Hara K; Honda H; Ide T; Kumashiro R; Kohara M; Sata M; Watanabe H; Hamada N
    Arch Virol; 2008; 153(8):1575-9. PubMed ID: 18592133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses.
    Dasgupta A; Das S; Izumi R; Venkatesan A; Barat B
    FEMS Microbiol Lett; 2004 May; 234(2):189-99. PubMed ID: 15135522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice.
    McCaffrey AP; Meuse L; Karimi M; Contag CH; Kay MA
    Hepatology; 2003 Aug; 38(2):503-8. PubMed ID: 12883495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatitis C virus IRES-mediated translation by oligonucleotides.
    Li X; Mueller S; Wimmer E
    Virus Res; 2009 Dec; 146(1-2):29-35. PubMed ID: 19720092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA.
    Paek KY; Kim CS; Park SM; Kim JH; Jang SK
    J Virol; 2008 Dec; 82(24):12082-93. PubMed ID: 18842733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin B12 stalls the 80 S ribosomal complex on the hepatitis C internal ribosome entry site.
    Takyar SS; Gowans EJ; Lott WB
    J Mol Biol; 2002 May; 319(1):1-8. PubMed ID: 12051931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling how ribavirin improves interferon response rates in hepatitis C virus infection.
    Dixit NM; Layden-Almer JE; Layden TJ; Perelson AS
    Nature; 2004 Dec; 432(7019):922-4. PubMed ID: 15602565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein.
    Li D; Lott WB; Martyn J; Haqshenas G; Gowans EJ
    J Virol; 2004 Nov; 78(21):12075-81. PubMed ID: 15479850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathway of HCV IRES-mediated translation initiation.
    Otto GA; Puglisi JD
    Cell; 2004 Oct; 119(3):369-80. PubMed ID: 15507208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.